ProfileGDS4132 / 227362_at
TitlePPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
OrganismHomo sapiens


pretreatment pioglitazone GSM201542 GSM201543 GSM201544 GSM201545 GSM201829 GSM201830 GSM201831 GSM201832 GSM201833 GSM201834 GSM201835 GSM201836 GSM201837 GSM201838 GSM201839 GSM201840 GSM201841 GSM201842 GSM201843 GSM201844 42% 44% 36% 32% 35% 39% 39% 41% 29% 35% 22% 30% 22% 21% 21% 23% 26% 27% 26% 24% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM201542Muscle PCOS pioglitazone 101110.23542
GSM201543Muscle PCOS pioglitazone 121106.73344
GSM201544Muscle PCOS pioglitazone 16194.281436
GSM201545Muscle PCOS pioglitazone 20186.424932
GSM201829Muscle PCOS pioglitazone 23195.5235
GSM201830Muscle PCOS pioglitazon 251103.38439
GSM201831Muscle PCOS pioglitazone 27199.226539
GSM201832Muscle PCOS pioglitazone 31106.45841
GSM201833Muscle PCOS pioglitazone 4166.061529
GSM201834Muscle PCOS pioglitazone 8185.89535
GSM201835Muscle PCOS after pioglitazone 10239.033822
GSM201836Muscle PCOS after pioglitazone 12264.006630
GSM201837Muscle PCOS after pioglitazone 16238.381822
GSM201838Muscle PCOS after pioglitazone 20242.190521
GSM201839Muscle PCOS after pioglitazone 23243.145921
GSM201840Muscle PCOS after pioglitazone 25250.019923
GSM201841Muscle PCOS after pioglitazone 27247.598426
GSM201842Muscle PCOS after pioglitazone 3251.26827
GSM201843Muscle PCOS after pioglitazone 4261.989626
GSM201844Muscle PCOS after pioglitazone 8251.339924